Sell signal in observation · week 4
Eli Lilly drops 3.4% as the bounce dies under the daily Kumo and the decline resumes
Our view last week
Eli Lilly bounced 3% off its 20-day moving average and closed the week up 2.6%, its second gain in a row, climbing back toward the Inversion Point in the 1206 area. After last week's stall, the technical analysis reads a decline fading out: signal strength drops to 2 out of 100. Volume in Eli Lilly stock has leaned to buyers for 2 weeks, but money flow is still below zero. Among US stocks on a sell signal, this is a high-risk place to open a short.
This week's summary
Eli Lilly's bounce died under the daily Kumo floor, in the 1186 area: the week closed down 3.4% after 2 straight gains, putting price back on its 20-week moving average in the 1137 area. A week ago our technical analysis read a decline fading out; now the slide has restarted and signal strength is picking up. Price action shows distribution and money flow has been negative for 5 weeks, with Eli Lilly stock still 44% above its 200-week average.
Sell signal in observation
·4th week from start
·US stocks
·T2
·📅 Earnings · Oct 29
★ See Gold version →
IQS Phase
75
in tension
Signal Strength
26
decline starting to make lower lows
Sizing
MINIMUM
Ranking
#97 / 175
US stocks sell signals
Trade P&L %
-2.43%
from signal to date, no stop loss
Eli Lilly (LLY) weekly chart — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
Rank position
ranks 97th among the 175 sell signals for US stocks in our ranking, with a signal strength of 26 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly -2.65% · monthly -3.91%
LLY belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.
restricted Platinum content